4/26
11:00 am
srpt
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Yahoo! Finance]
Low
Report
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Yahoo! Finance]
4/25
10:14 am
srpt
Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock [Yahoo! Finance]
Low
Report
Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock [Yahoo! Finance]
4/24
08:30 am
srpt
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
Medium
Report
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
4/23
03:20 pm
srpt
GSK Gears Up for Q1 Earnings: Here's What to Expect [Yahoo! Finance]
Low
Report
GSK Gears Up for Q1 Earnings: Here's What to Expect [Yahoo! Finance]
4/11
09:12 pm
srpt
IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus [Yahoo! Finance]
Low
Report
IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus [Yahoo! Finance]
4/11
02:36 am
srpt
Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy [Seeking Alpha]
Low
Report
Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy [Seeking Alpha]
4/8
04:15 pm
srpt
Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts [Seeking Alpha]
Low
Report
Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts [Seeking Alpha]
4/6
08:53 am
srpt
2 Biotech Stocks to Buy Hand Over Fist in April [Yahoo! Finance]
Medium
Report
2 Biotech Stocks to Buy Hand Over Fist in April [Yahoo! Finance]
4/2
01:38 am
srpt
Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance [Yahoo! Finance]
Low
Report
Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance [Yahoo! Finance]
3/29
04:00 pm
srpt
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/29
12:57 pm
srpt
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Medium
Report
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
3/29
09:34 am
srpt
Sarepta Therapeutics' (NASDAQ:SRPT) growing losses don't faze investors as the stock increases 3.6% this past week [Yahoo! Finance]
Medium
Report
Sarepta Therapeutics' (NASDAQ:SRPT) growing losses don't faze investors as the stock increases 3.6% this past week [Yahoo! Finance]
3/22
11:14 am
srpt
FDA clears first-of-its-kind Duchenne drug for broad use [Yahoo! Finance]
Low
Report
FDA clears first-of-its-kind Duchenne drug for broad use [Yahoo! Finance]
3/21
02:19 am
srpt
Hansa Biopharma publishes 2023 Annual and Sustainability Reports [Yahoo! Finance]
Low
Report
Hansa Biopharma publishes 2023 Annual and Sustainability Reports [Yahoo! Finance]
3/20
12:21 pm
srpt
Kyowa Kirin's rare disease therapy becomes world's most expensive drug [Seeking Alpha]
Low
Report
Kyowa Kirin's rare disease therapy becomes world's most expensive drug [Seeking Alpha]
3/11
02:12 pm
srpt
Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D [Yahoo! Finance]
Low
Report
Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D [Yahoo! Finance]
3/8
05:56 am
srpt
Got $1,000? Buy These Hot Growth Stocks Before They Take Off. [Yahoo! Finance]
Low
Report
Got $1,000? Buy These Hot Growth Stocks Before They Take Off. [Yahoo! Finance]
3/7
12:13 am
srpt
Director Stephen Mayo Sells 3,135 Shares of Sarepta Therapeutics Inc (SRPT) [Yahoo! Finance]
Low
Report
Director Stephen Mayo Sells 3,135 Shares of Sarepta Therapeutics Inc (SRPT) [Yahoo! Finance]
3/5
06:21 pm
srpt
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating.
Low
Report
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating.
3/4
09:57 am
srpt
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst [Yahoo! Finance]
Low
Report
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst [Yahoo! Finance]
3/4
09:11 am
srpt
Science Continues To Outpace Commercialization Of Cell And Gene Therapies [Forbes]
Low
Report
Science Continues To Outpace Commercialization Of Cell And Gene Therapies [Forbes]
3/4
08:30 am
srpt
Sarepta Therapeutics to Present at Upcoming Investor Conferences
Low
Report
Sarepta Therapeutics to Present at Upcoming Investor Conferences
3/2
07:28 am
srpt
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]
Medium
Report
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]
3/2
12:10 am
srpt
Decoding Sarepta Therapeutics Inc (SRPT): A Strategic SWOT Insight [Yahoo! Finance]
Medium
Report
Decoding Sarepta Therapeutics Inc (SRPT): A Strategic SWOT Insight [Yahoo! Finance]
3/1
11:48 am
srpt
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at UBS Group AG from $164.00 to $167.00. They now have a "buy" rating on the stock.
Low
Report
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at UBS Group AG from $164.00 to $167.00. They now have a "buy" rating on the stock.